Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$122.20
-4.41-3.48%
al cierre: -
$120.76
-1.44-1.18%
After hour: Oct 10, 5:35 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Itron Inc ha un obiettivo di prezzo di consenso pari a $112.65, stabilito in base alle ultime valutazioni degli analisti di 18. Le ultime 3 valutazioni degli analisti sono state rilasciate da Stephens & Co., JP Morgan y Roth Capital il octubre 7, 2025, julio 31, 2025 y julio 22, 2025. Con un obiettivo di prezzo medio di $141.67 tra le Stephens & Co., JP Morgan y Roth Capital, c'è un implicito 17.31% upside per Itron Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Stephens & Co.
JP Morgan
Roth Capital
Guggenheim
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Itron
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/07/2025 | 7.65% | Stephens & Co. | $130 → $130 | Reiterates | Equal-Weight → Equal-Weight | |||
07/31/2025 | 20.07% | JP Morgan | $128 → $145 | Upgrade | Neutral → Overweight | |||
07/22/2025 | 24.21% | Roth Capital | $130 → $150 | Maintains | Buy | |||
07/22/2025 | 5.99% | JP Morgan | $118 → $128 | Maintains | Neutral | |||
07/14/2025 | 28.35% | Guggenheim | $133 → $155 | Maintains | Buy | |||
05/05/2025 | 0.2% | Piper Sandler | $124 → $121 | Maintains | Neutral | |||
04/17/2025 | 10.13% | Guggenheim | $133 → $133 | Reiterates | Buy → Buy | |||
02/27/2025 | 10.13% | Guggenheim | $135 → $133 | Maintains | Buy | |||
02/27/2025 | 2.68% | Piper Sandler | $119 → $124 | Maintains | Neutral | |||
02/26/2025 | 9.31% | Canaccord Genuity | $130 → $132 | Maintains | Buy | |||
02/26/2025 | 8.48% | Oppenheimer | $124 → $131 | Maintains | Outperform | |||
11/06/2024 | 11.79% | Guggenheim | $128 → $135 | Maintains | Buy | |||
11/01/2024 | 12.62% | TD Cowen | $125 → $136 | Maintains | Buy | |||
11/01/2024 | 7.65% | Roth MKM | $125 → $130 | Maintains | Buy | |||
11/01/2024 | -1.46% | Piper Sandler | $110 → $119 | Maintains | Neutral | |||
11/01/2024 | 2.68% | Oppenheimer | $120 → $124 | Maintains | Outperform | |||
11/01/2024 | 9.31% | Baird | $123 → $132 | Maintains | Outperform | |||
09/27/2024 | 8.48% | Janney Montgomery Scott | → $131 | Initiates | → Buy | |||
08/21/2024 | 3.51% | Roth MKM | $125 → $125 | Maintains | Buy | |||
08/05/2024 | -8.91% | Stephens & Co. | $110 → $110 | Reiterates | Equal-Weight → Equal-Weight | |||
08/02/2024 | 3.51% | Roth MKM | $122 → $125 | Maintains | Buy | |||
08/02/2024 | 1.85% | Baird | $115 → $123 | Maintains | Outperform | |||
07/22/2024 | -8.91% | Piper Sandler | $109 → $110 | Maintains | Neutral | |||
07/17/2024 | -7.26% | Oppenheimer | $110 → $112 | Maintains | Outperform | |||
07/16/2024 | -7.26% | JP Morgan | $104 → $112 | Maintains | Neutral | |||
07/16/2024 | 1.02% | Roth MKM | $112 → $122 | Maintains | Buy | |||
07/11/2024 | 7.65% | Guggenheim | → $130 | Upgrade | Neutral → Buy | |||
06/20/2024 | -0.63% | Canaccord Genuity | $115 → $120 | Maintains | Buy | |||
05/21/2024 | -9.74% | Piper Sandler | $109 → $109 | Downgrade | Overweight → Neutral | |||
05/06/2024 | -8.91% | Stephens & Co. | $85 → $110 | Maintains | Equal-Weight | |||
05/03/2024 | -4.77% | Canaccord Genuity | $105 → $115 | Maintains | Buy | |||
05/03/2024 | -4.77% | TD Cowen | $110 → $115 | Maintains | Buy | |||
05/03/2024 | -7.26% | Roth MKM | $102 → $112 | Maintains | Buy | |||
05/03/2024 | -9.74% | Piper Sandler | $103 → $109 | Reiterates | Overweight → Overweight | |||
05/03/2024 | -8.91% | Oppenheimer | $100 → $110 | Maintains | Outperform | |||
04/23/2024 | -15.54% | Roth MKM | → $102 | Maintains | Buy | |||
04/11/2024 | -14.71% | Piper Sandler | $105 → $103 | Maintains | Overweight | |||
03/13/2024 | -8.91% | TD Cowen | $107 → $110 | Maintains | Outperform | |||
03/13/2024 | -4.77% | Baird | $108 → $115 | Maintains | Outperform | |||
03/13/2024 | -23.82% | JP Morgan | $77 → $92 | Maintains | Neutral | |||
02/27/2024 | -13.05% | Piper Sandler | $91 → $105 | Maintains | Overweight | |||
02/27/2024 | -10.57% | Baird | $68 → $108 | Upgrade | Neutral → Outperform | |||
01/19/2024 | -32.93% | Oppenheimer | → $81 | Upgrade | Perform → Outperform | |||
01/04/2024 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
12/19/2023 | -24.65% | Piper Sandler | $72 → $91 | Upgrade | Neutral → Overweight | |||
12/12/2023 | -43.69% | JP Morgan | → $68 | Upgrade | Underweight → Neutral | |||
12/05/2023 | -32.1% | Roth MKM | → $82 | Initiates | → Buy | |||
12/01/2023 | -43.69% | Canaccord Genuity | → $68 | Initiates | → Hold | |||
11/03/2023 | -40.38% | Piper Sandler | $71 → $72 | Maintains | Neutral | |||
10/19/2023 | -46.18% | JP Morgan | $72 → $65 | Maintains | Underweight | |||
10/06/2023 | -41.21% | Piper Sandler | $63 → $71 | Maintains | Neutral | |||
09/22/2023 | -33.75% | Seaport Global | → $80 | Initiates | → Buy | |||
09/11/2023 | — | Guggenheim | — | Initiates | → Neutral | |||
08/18/2023 | -32.1% | Argus Research | → $82 | Upgrade | Hold → Buy | |||
08/04/2023 | -21.33% | TD Cowen | $85 → $95 | Maintains | Outperform | |||
08/04/2023 | -37.89% | Baird | $63 → $75 | Maintains | Neutral | |||
07/12/2023 | — | Raymond James | — | Downgrade | Strong Buy → Outperform | |||
05/08/2023 | -47.83% | Piper Sandler | $58 → $63 | Maintains | Neutral | |||
05/05/2023 | -42.04% | EF Hutton | $60 → $70 | Maintains | Buy | |||
05/05/2023 | -47.83% | Baird | $52 → $63 | Maintains | Neutral | |||
05/05/2023 | -42.04% | Raymond James | $60 → $70 | Maintains | Strong Buy | |||
03/03/2023 | -58.6% | JP Morgan | $53 → $50 | Downgrade | Neutral → Underweight | |||
02/28/2023 | -62.74% | Stephens & Co. | → $45 | Reiterates | → Equal-Weight | |||
02/28/2023 | -51.97% | Piper Sandler | $48 → $58 | Maintains | Neutral | |||
02/28/2023 | -56.94% | Baird | $40 → $52 | Maintains | Neutral | |||
02/28/2023 | -50.32% | EF Hutton | → $60 | Reiterates | → Buy | |||
02/28/2023 | -50.32% | Raymond James | $57 → $60 | Maintains | Strong Buy | |||
02/02/2023 | -40.38% | Cowen & Co. | $55 → $72 | Maintains | Outperform | |||
11/04/2022 | -58.6% | Morgan Stanley | $55 → $50 | Maintains | Equal-Weight | |||
11/04/2022 | -50.32% | EF Hutton | $72 → $60 | Maintains | Buy | |||
11/04/2022 | -52.8% | Raymond James | $68 → $57 | Maintains | Strong Buy | |||
10/20/2022 | -51.97% | JP Morgan | $65 → $58 | Maintains | Neutral |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Itron (ITRI)?
El último precio objetivo de Itron (NASDAQ:ITRI) fue comunicado por Stephens & Co. el octubre 7, 2025. La firma de analistas fijó un precio objetivo para $130.00 que espera ITRI a rise dentro de 12 meses (un posible 7.65% upside). 17 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Itron (ITRI)?
La última calificación de analistas para Itron (NASDAQ:ITRI) fue proporcionada por Stephens & Co., y Itron reiterado su equal-weight calificación.
¿Cuándo se produjo la última revisión al alza de Itron (ITRI)?
La última revisión al alza de Itron Inc se produjo en julio 31, 2025, cuando JP Morgan elevó su precio objetivo a $145. JP Morgan anteriormente tenía a neutral para Itron Inc.
¿Cuándo fue la última revisión a la baja de Itron (ITRI)?
La última revisión a la baja de Itron Inc se produjo en mayo 21, 2024, cuando Piper Sandler cambió su precio objetivo de $109 a $109 para Itron Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Itron (ITRI)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Itron, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Itron se registró el octubre 7, 2025, por lo que la próxima calificación estará disponible en torno al octubre 7, 2026.
¿Es correcta la calificación de los analistas sobre Itron (ITRI)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Itron (ITRI) fue un reiterado con un precio objetivo de $130.00 a $130.00. El precio actual al que cotiza Itron (ITRI) es de $120.76, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.